RARE•benzinga•
Ultragenyx Pharmaceutical Sees FY25 Revenue $640M-$670M Vs $652.946M Est.
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 13, 2025 by benzinga